题名 | Ibrutinib plus fludarabine, cyclophosphamide, and rituximab as initial treatment for younger patients with chronic lymphocytic leukaemia: a single-arm, multicentre, phase 2 trial | 作者 | Matthew SDavidsMD | 杂志 | The Lancet Haematology | 年|卷|期 | Volume 6, Issue 8August 2019 Pages e419-e428 | 链接 | https://www.sciencedirect.com/science/article/abs/pii/S2352302619301048 |
本帖最后由 初学者 于 2020-2-21 22:13 编辑
紧急求助附录!附录!附录!Supplementary appendix |